Covista Inc. (CVSA) company profile
Close on Nov 17, 2026Market cap $3.89BP/E 16.0Yield –
About Covista
Services-Educational Services, SIC 8200
Covista Inc. provides postsecondary healthcare and professional education across five accredited institutions. Its business operates in three reportable segments: Chamberlain, Walden, and Medical and Veterinary. Chamberlain provides onsite and online degree and certificate programs in nursing and health professions. Walden provides online undergraduate and graduate degrees across diverse fields, including nursing, education, counseling, business, behavioral sciences, and public health. The Medical and Veterinary segment encompasses the American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine, conferring medical and veterinary degrees. The company's primary customers are adult learners, working professionals, and aspiring healthcare practitioners.
The company educates approximately 100,000 students through both digital instruction and physical campuses across several locations. Its network includes 24 Chamberlain campuses across 16 states, medical and veterinary campuses in St. Maarten, Barbados, and St. Kitts, and a medical satellite facility in the United Kingdom. Covista maintains its executive headquarters in Chicago, Illinois.
Summary of the business section of Covista's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Covista Inc.
- Founded
- 1987
- Headquarters
- Chicago, IL
- Address
- 233 S. Wacker Drive, Suite 800 60606
- Phone
- (312) 651-1400
- Website
- www.covista.com
- Employees
- 510, Jun 30, 2007
- Industry
- Services-Educational Services
- Incorporated in
- Delaware
- Fiscal year ends
- June 30
- Auditor
- PricewaterhouseCoopers LLP, Chicago, Illinois
Stock & identifiers
- Ticker
- CVSA
- Former tickers
- ATGE until Feb 24, 2026; AGTE until Jan 25, 2022; DV until Aug 24, 2017
- Exchange
- NYSE
- IPO date
- Mar 27, 1997
- Shares outstanding
- 33M, Oct 23, 2026
- Public float
- $3.49B, Dec 31, 2025
- Filer category
- Large accelerated filer
- Stock splits
- 2-for-1, Jun 22, 1998; 2-for-1, Dec 19, 1996; 2-for-1, Jun 22, 1995
- SEC CIK
- 730464
- CUSIP
- 00737L103
- ISIN
- US00737L1035
- FIGI
- BBG000DQBZJ7
- Share class FIGI
- BBG001S8M5S3
- LEI
- 549300Z467EZLMODV621
- EIN
- 36-3150143
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Manjunath Gangadharan | VP, Chief Accounting Officer | 5,735 |
| Robert J. Phelan | Chief Financial Officer | 58,768 |
| Douglas G. Beck | SVP, GC, Corp. Sec & ISS | 34,399 |
| Scott Liles | President, Medical and Vet | 15,317 |
| Michael Betz | Pres. Walden Univ. & SVP-CGIO | 55,647 |
| Beard, Stephen W. | Chairman & CEO | 459,953 |
| Megan Noel | Chief Corp. Affairs Officer | 3,773 |
| Amelia Manning | President, Chamberlain Univ. | 6,199 |
| Sara Hill | CHRO | 10,258 |
| Karen Sue Cox | President, Chamberlain Univ. | 31,596 |
| Evan Trent | President, Adtalem Elevate | 24,134 |
| Maurice Herrera | SVP - Chief Marketing Officer | 20,584 |
| Blake Simpson | SVP, Chief Comms & CA Officer | 8,795 |
| Michael W. Malafronte | Director | 136,868 |
| Emily C. Chiu | Director | 1,404 |
| Leslie Storms | Director | 1,429 |
| Kenneth J. Phelan | Director | 20,728 |
| William W. Burke | Director | 11,316 |
| Sharon O'Keefe | Director | 17,852 |
| Georgette D. Kiser | Director | 18,345 |
| Donna J. Hrinak | Director | 9,155 |
| Betty M. Vandenbosch | Director | 3,449 |
| William V. Krehbiel | Director | 17,168 |
| Lisa W. Wardell | Director | 44,251 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2026 | $19.02M | $27.99M | $2.48M | $350 | $226 |
| FY2025 | $17.24M | $72.12M | $1.97M | $357 | $205 |
| FY2024 | $14.30M | $30.03M | $2.39M | $191 | $157 |
| FY2023 | $8.05M | $8.41M | $1.70M | $96 | $111 |
| FY2022 Lisa WWardell | $6.28M | $6.76M | $1.85M | $101 | $105 |
| FY2022 Stephen WBeard | $9.20M | $8.97M | $1.85M | $101 | $105 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2026
Summary compensation table from the latest proxy statement
| Executive | Salary | Stock awards | Incentive pay | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|
| Stephen W. Beard Chairman and Chief Executive Officer | $1.00M | $16.00M | $1.81M | $206.42K | $19.02M | +10% |
| Robert J. Phelan Senior Vice President and Chief Financial Officer | $555.08K | $1.38M | $514.66K | $25.43K | $2.47M | +23% |
| Douglas G. Beck Senior Vice President, General Counsel, Corporate Secretary and Institutional Support Services | $540.97K | $669.98K | $482.79K | $79.13K | $1.77M | +7% |
| Michael Betz Chief Growth & Innovation Officer and President, Walden University | $696.92K | $1.80M | $958.65K | $121.13K | $3.58M | +38% |
| Scott Liles President Medical & Veterinary | $542.35K | $843.75K | $665.35K | $58.68K | $2.11M | +30% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
Corporate history
Events identified from SEC filings
See a number that looks wrong?